CIPLA 323 (Dimethyl Fumarate Delayed-Release 240 mg)
Pill with imprint CIPLA 323 is Green, Capsule-shape and has been identified as Dimethyl Fumarate Delayed-Release 240 mg. It is supplied by Cipla USA Inc.
Dimethyl fumarate is used in the treatment of multiple sclerosis and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Dimethyl fumarate 240 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CIPLA 323
Dimethyl Fumarate Delayed-Release
- Imprint
- CIPLA 323
- Strength
- 240 mg
- Color
- Green
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- Manufacturer
- MSN Laboratories Private
- National Drug Code (NDC)
- 69097-0323
More about dimethyl fumarate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (98)
- Drug images
- Pricing & coupons
- En español
- Drug class: selective immunosuppressants
Patient resources
- Other brands
- Tecfidera
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.